DAFNA Capital Management LLC

Q3 2025 13F Holdings

  • Location
    los angeles, CA
  • Num holdings

    75

  • Value ($000)

    $404,786

  • Date Filed
    11/14/2025
  • Form type
    13F-HR
  • CIK
    0001389933
  • All SEC filings
  • Note
    Holdings aggregated across “other managers” listed in original SEC filing, see here for detailed holdings broken out by other managers
Compare Q3 2025 to
Select Quarter
Issuer Name
Class
CUSIP
VALUE
%
Shares
Principal
Option Type
R
RJR1

STEREOTAXIS INC

COM NEW
85916J409
$42.55M
11 %

13,680,554

K
KRE

SPDR S&P BIOTECH ETF

ETF
78464A870
$40.23M
10 %

401,505

R
RVMD

REVOLUTION MEDICINES INC

COM
76155X100
$30.69M
8 %

657,176

C
CYTK

CYTOKINETICS INC

COM NEW
23282W605
$21.71M
5 %

394,940

A
ATRC

ATRICURE INC

COM
04963C209
$20.88M
5 %

592,273

---

MERUS BV

COM
N5749R100
$20.76M
5 %

220,451

I
IBB

ISHARES NASDAQ BIOTECH INDX

ETF
464287556
$14.80M
4 %

102,500

I
IDYA

IDEAYA BIOSCIENCES INC

COM
45166A102
$14.69M
4 %

539,923

A
AXGN

AXOGEN INC

COM
05463X106
$13.24M
3 %

742,282

---

XENON PHARMACEUTICALS INC

COM
98420N105
$11.56M
3 %

287,939

Rows Per Page
10
  • 10
  • 50
  • 100
1 - 10 of 75